Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Casey A Maguire

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Molecular Therapy. Nucleic Acids|July 25, 2013
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular VesiclesWalter W Chen, Leonora Balaj, Linda M Liau, et al.
Science Advances|February 1, 2021
Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberinPike-See Cheah, Shilpa Prabhakar, David Yellen, et al.
Journal of Neuro-Oncology|May 17, 2018
Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous deliveryAdrienn Volak, Stanley G LeRoy, Jeya Shree Natasan, et al.
Molecular Therapy. Methods & Clinical Development|November 11, 2024
An <i>in vitro</i> and <i>in vivo</i> efficacy evaluation of gene therapy candidate SBT101 in mouse models of adrenomyeloneuropathy and in NHPsVidyullatha Vasireddy, Casey A Maguire, David W Anderson, et al.
Human Gene Therapy|June 28, 2023
An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain VasculatureServio H Ramirez, Jonathan F Hale, Siobhan McCarthy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 7, 2024
In vivo selection in non-human primates identifies AAV capsids for on-target CSF delivery to spinal cordKillian S Hanlon, Ming Cheng, Roberto Montoro Ferrer, et al.
Gene Therapy|June 10, 2025
Engineered AAV capsids mediate transduction of murine neurofibroma and sciatic nerveEdwina Abou Haidar, Shilpa Prabhakar, Pike See Cheah, et al.
Molecular Therapy. Methods & Clinical Development|December 25, 2018
Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human PrimateBence György, Elise J Meijer, Maryna V Ivanchenko, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 28, 2016
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene TherapySourav R Choudhury, Zachary Fitzpatrick, Anne F Harris, et al.
Nature Communications|October 2, 2019
High levels of AAV vector integration into CRISPR-induced DNA breaksKillian S Hanlon, Benjamin P Kleinstiver, Sara P Garcia, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Molecular Therapy. Nucleic Acids|July 25, 2013
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular VesiclesWalter W Chen, Leonora Balaj, Linda M Liau, et al.
Science Advances|February 1, 2021
Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberinPike-See Cheah, Shilpa Prabhakar, David Yellen, et al.
Journal of Neuro-Oncology|May 17, 2018
Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous deliveryAdrienn Volak, Stanley G LeRoy, Jeya Shree Natasan, et al.
Molecular Therapy. Methods & Clinical Development|November 11, 2024
An <i>in vitro</i> and <i>in vivo</i> efficacy evaluation of gene therapy candidate SBT101 in mouse models of adrenomyeloneuropathy and in NHPsVidyullatha Vasireddy, Casey A Maguire, David W Anderson, et al.
Human Gene Therapy|June 28, 2023
An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain VasculatureServio H Ramirez, Jonathan F Hale, Siobhan McCarthy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 7, 2024
In vivo selection in non-human primates identifies AAV capsids for on-target CSF delivery to spinal cordKillian S Hanlon, Ming Cheng, Roberto Montoro Ferrer, et al.
Gene Therapy|June 10, 2025
Engineered AAV capsids mediate transduction of murine neurofibroma and sciatic nerveEdwina Abou Haidar, Shilpa Prabhakar, Pike See Cheah, et al.
Molecular Therapy. Methods & Clinical Development|December 25, 2018
Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human PrimateBence György, Elise J Meijer, Maryna V Ivanchenko, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 28, 2016
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene TherapySourav R Choudhury, Zachary Fitzpatrick, Anne F Harris, et al.
Nature Communications|October 2, 2019
High levels of AAV vector integration into CRISPR-induced DNA breaksKillian S Hanlon, Benjamin P Kleinstiver, Sara P Garcia, et al.
Pageof 8